Profil
Bruce G.
McCarthy held several positions in the pharmaceutical industry, including Chief Executive Officer & Director at Afferent Pharmaceuticals, Inc. from 2010 to 2014, Medical Director at Abbott Laboratories from 1997 to 2004, Vice President-Neuroscience Development at Pfizer Inc., and Chief Medical Officer & VP-Drug Development at Mithridion, Inc. He also served as Chief Marketing Officer & VP-Clinical Development at Embera NeuroTherapeutics, Inc. in 2009-2010.
McCarthy received his undergraduate degree from Stanford University, his MBA from Northwestern University, and his doctorate from The Johns Hopkins University.
Anciens postes connus de Bruce G. McCarthy
| Sociétés | Poste | Fin |
|---|---|---|
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Chief Executive Officer | 10/09/2014 |
| ABBOTT LABORATORIES | Chief Tech/Sci/R&D Officer | - |
Embera NeuroTherapeutics, Inc.
 Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Chief Tech/Sci/R&D Officer | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Mithridion, Inc.
 Mithridion, Inc. Pharmaceuticals: MajorHealth Technology Mithridion, Inc. develops and manufactures biopharmaceutical products. Its drugs are used for the treatment of Alzheimer's's disease and schizophrenia. The company was founded on November 19, 2004 and is headquartered in Madison, WI. | Chief Tech/Sci/R&D Officer | - |
Formation de Bruce G. McCarthy
| Stanford University | Undergraduate Degree |
| Northwestern University | Masters Business Admin |
| The Johns Hopkins University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Mithridion, Inc.
Mithridion, Inc. Pharmaceuticals: MajorHealth Technology Mithridion, Inc. develops and manufactures biopharmaceutical products. Its drugs are used for the treatment of Alzheimer's's disease and schizophrenia. The company was founded on November 19, 2004 and is headquartered in Madison, WI. | Health Technology |
Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Health Technology |
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Health Technology |
